---
notetoolbar: Study
share_link: https://share.note.sx/k1toegs4#qK2JL9Bh9YDbzh/qp0wBWW4tKEU5BlkEUCLyPcL7ZYI
share_updated: 2024-06-18T19:07:57+08:00
---

> [!scroller] Table of Contents
> ```table-of-contents
> ```

# HEMATOPOEISIS
## Erythropoeisis

- Key regulatory factors for Erythropoeisis
	- Erythropoeitin
	- GM-CSF
- (18 - 21 days) BFU → mature RBC

|                                      |                                                                   |                                                                                                                                                                                                                                                                                                                                                                        |
| ------------------------------------ | ----------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| ![[Pasted image 20240429145333.png]] | <mark class="red">PROnormoblast (Rubriblast)</mark>               | - Size: **12 – 25 um**<br>- NC Ratio: **8:1**<br>- Nucleus: **fine and uniform chromatin pattern** with **prominent nuclear membrane**; one or more nucleoli are present<br>- Cytoplasm: **heterogenous** quality and is moderate in amount and basophilia, **no granules** are present.<br><br>- GLOBIN production BEGINS                                             |
| ![[Pasted image 20240429145342.png]] | <mark class="red">BASOPHILIC Normoblast (Prorubricyte)</mark>     | - Size: **12 – 17 um**<br>- NC Ratio: **6:1**<br>- Nucleus: **Centrally** located with **coarser chromatin** pattern that may be **partially clumped**; **distinct pink-staining parachromatin**; **nucleolus (+)** not visible<br>- Cytoplasm: **Intensely basophilic** due to abundance of RNA<br><br>- Hemoglobin production STARTS                                 |
| ![[Pasted image 20240429145358.png]] | <mark class="red">POLYCHROMATIC Normoblast (Rubricyte)</mark>     | - Size: **12 – 15 um**<br>- NC Ratio: **4:1**<br>- Nucleus: **More condensed** and occupies about half of the cell area; **condensed coarse chromatin** with a **more distinct parachromatin**; stains intensely<br>- Cytoplasm: **blue-gray to pink-gray** (polychromatophilic/ polychromasia)<br><br>- Hemoglobin becomes evident<br>- LAST stage capable of MITOSIS |
| ![[Pasted image 20240429145414.png]] | <mark class="red">ORTHOCHROMIC Normoblast (Metarubricyte)</mark>  | - Size: **8 – 12 um**<br>- NC Ratio: **1:2**<br>- Nucleus: **pyknotic** (a small, homogenous blue-black mass with no structure)<br>- Cytoplasm: **abundant hemoglobin** and **fewer polyribosomes** and pinkish pale violet- blue gray (slightly polychromatophilic)<br><br>- LAST NUCLEATED phase                                                                     |
| ![[Pasted image 20240429145421.png]] | <mark class="red">POLYCHROMATIC Erythrocyte (Reticulocyte)</mark> | - Size: **7 – 20 um**<br>- Nucleus: NONE<br>- Cytoplasm: **pink to slight pinkish gray** (polychromasia) as a result of the retention of RNA<br><br>- 1st stage to be released in the PERIPHERAL CIRCULATION (stays only for approx. 1-2 days)                                                                                                                         |
| ![[Pasted image 20240429145432.png]] | <mark class="red">Erythrocyte</mark>                              | - Size: **6 – 8 um**<br>- Nucleus: NONE<br>- Cytoplasm: **pink to reddish pink**                                                                                                                                                                                                                                                                                       |

## Granulopoeisis
- Key regulators
	- GM-CSF
	- G-CSF
	- IL-5 (Eosinophils)
	- IL-3, IL-4 (Basophils)

|                                      |                                                   | Size                                   | N:C               | Nucleus                                                                                                               | Cytoplasm                                                                                      |                                                                                                                                                                                                                                                                                                             |
| ------------------------------------ | ------------------------------------------------- | -------------------------------------- | ----------------- | --------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| ![[Pasted image 20240429145451.png]] | <mark class="red">MyeloBLAST</mark>               | Large                                  | High              | Large, round or oval with 2 or more nucleoli <br>Fine chromatin pattern <br>Reddish purple                            | **Deeply basophilic** <br>Scanty <br>Usually **lacks granules**                                | **CD<mark class="red">34</mark>, ↑ CD<mark class="red">55</mark>**                                                                                                                                                                                                                                          |
| ![[Pasted image 20240429145459.png]] | <mark class="red">Promyelocyte</mark>             | May be slightly larger than myeloblast | High              | Large, round or oval with 2 or more nucleoli <br>Fine chromatin pattern <br>Reddish purple                            | **Basophilic** cytoplasm <br>Few to many <br>prominent dark red or purple **primary granules** | **(-)CD<mark class="red">34</mark>, ↓ CD<mark class="red">55</mark>**<br><br>**(+) CD<mark class="red">66b</mark>**                                                                                                                                                                                         |
| ![[Pasted image 20240429145508.png]] | <mark class="red">Myelocyte</mark>                | Decreased from blast                   | **Slightly High** | Becoming more clumped <br>No nucleoli visible <br>Often **eccentrically located** <br>Reddish purple                  | **Few primary granules** but **specific granules** begin to appear <br>Bluish pink cytoplasm   | Morphologically recognizable stage (differentiate the type of granulocyte to become)<br>- Last stage capable of MITOSIS<br><br>**(-)CD<mark class="red">45r</mark>, CD<mark class="red">117</mark>**<br>**(+)CD<mark class="red">11</mark>, CD<mark class="red">24</mark>, Cd<mark class="red">66a</mark>** |
| ![[Pasted image 20240429145516.png]] | <mark class="red">Metamyelocyte</mark>            | Decreased from blast                   | **Equal**         | Chromatin condensed and clumped <br>Darker purple <br>**Indented or kidney bean shaped** <br>**NO nucleoli**          | **Many specific granules** <br>Pink cytoplasm                                                  | Juvenile cell<br><br>**(+)CD<mark class="red">16</mark>**                                                                                                                                                                                                                                                   |
| ![[Pasted image 20240429145533.png]] | <mark class="red">Band/Stab</mark>                | Slightly smaller than meta             | Low               | **U or C shaped** of uniform thickness <br>Clumped and condensed chromatin <br>**NO nucleoli** <br>Deep purple        | **Many specific granules** <br>Pink cytoplasm                                                  | 1st stage normally found in the PERIPHERAL CIRCULATION<br><br>consider band/stab as neutrophil in counting<br><br>**(-)CD<mark class="red">18</mark>, CD<mark class="red">49d</mark>, CD<mark class="red">64</mark>**<br>**(+)CD<mark class="red">35</mark>, CD<mark class="red">87</mark>**                |
| ![[Pasted image 20240429145541.png]] | <mark class="red">PMN Neutrophil/Segmenter</mark> | About as same as band                  | Low               | **Distinct lobes** visible connected by chromatin strand <br>**2-5 lobes** possible <br>Clumped chromatin Deep purple | **Many specific granules** <br>Pink cytoplasm                                                  | **(+)CD<mark class="red">10</mark>, CD<mark class="red">14</mark>**                                                                                                                                                                                                                                         |

^kfzagh

## MORPHOLOGIC CHANGES THAT OCCUR DURING NORMAL BLOOD CELL MATURATION

| FEATURES             | <mark class="red">YOUNGER</mark>                                              | <mark class="red">MORE MATURE</mark>                             |
| -------------------- | ----------------------------------------------------------------------------- | ---------------------------------------------------------------- |
| Nuclear chromatin    | fine and delicate                                                             | **coarse** and clumped                                           |
| Cytoplasmic staining | more basophilic (takes up more basic dye because of abundant cytoplasmic RNA) | **Less basophilic** (less blue and takes up **more acidic** dye) |
| N:C ratio            | **High** (cell volume mostly occupied by the nucleus)                         | **Low** (higher cytoplasmic volume vs. nuclear volume)           |
| Other                | **Nucleoli** usually present<br>Cell is larger in size                        | Nucleoli ABSENT<br>**Cell is smaller**                           |
| #table-column        | usually characteristic of MALIGNANT cells; lack differentiation               |                                                                  |

^xkzf1s

# HEMOGLOBIN

![[Pasted image 20240508151950.png]]

|                                                                                        |                                                        |                                                                                                                                                                                                                                                         |
| -------------------------------------------------------------------------------------- | ------------------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">HEME</mark> Synthesis<br><br>**mitochondria**, **cytoplasm/cytosol** | <mark class="red">Iron absorption and transport</mark> | - <mark class="red">4</mark>: iron atoms in each hemoglobin molecule<br>- <mark class="red">Fe2+ (Ferrous)</mark>: state of iron                                                                                                                        |
| ^                                                                                      | <mark class="red">Protoporphyrin</mark> formation      | - **Final product** in hemoglobin synthesis                                                                                                                                                                                                             |
| ^                                                                                      | <mark class="red">Insertion of iron</mark>             | - **Transferrin receptors in the pronormoblast bind iron** for incorporation during erythropoiesis<br><br>- <mark class="red">Ferrochelatase</mark> (important enzyme)                                                                                  |
| <mark class="red">GLOBIN</mark> Synthesis<br><br>**ribosomes**                         | <mark class="red">Genetic control</mark>               | - Chromosome <mark class="red">11</mark>: **1 gene each** for production of **epsilon**, **beta**, **gamma** and **delta** chains<br>- Chromosome <mark class="red">16</mark>: **3 genes** for the production of **alpha (2)** and **zeta (1) chains**. |
| ^                                                                                      | <mark class="red">Globin chain structure</mark>        | - **Alpha** chains have <mark class="red">141</mark> amino acids<br>- **Beta** chains have <mark class="red">146</mark> amino acids                                                                                                                     |

## Molecular Structure of Normal Hemoglobins
| Hemoglobin                             | Structure                                   | Remarks                                                 |
| -------------------------------------- | ------------------------------------------- | ------------------------------------------------------- |
| <mark class="red">Gower 1</mark>       | <mark class="red">2 zeta, 2 epsilon</mark>  | Embryonic H                                             |
| <mark class="red">Gower 2</mark>       | <mark class="red">2 alpha, 2 epsilon</mark> | Embryonic H                                             |
| <mark class="red">Portland</mark>      | <mark class="red">2 zeta, 2 gamma</mark>    | Embryonic H                                             |
| Hemoglobin <mark class="red">A</mark>  | 2 alpha, <mark class="red">2 beta</mark>    | Adult H<br><br>95 - 98% (adults)<br>10 - 40% (newborns) |
| Hemoglobin <mark class="red">A2</mark> | 2 alpha, <mark class="red">2 delta</mark>   | Adult H<br><br>3 - 5% (adults)<br><2% (newborns)        |
| Hemoglobin <mark class="red">F</mark>  | 2 alpha, <mark class="red">2 gamma</mark>   | Adult H<br><br><2% (adults)<br>>=60% (newborns)         |

^n81rhv

## Abnormal Hemoglobin Derivatives

|                                            |                                                                                                                                                                                           |
| ------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">Carboxyhemoglobin</mark> | Affinity of oxygen is **200x higher** than normal<br><br>**cherry-red** blood                                                                                                             |
| <mark class="red">Methemoglobin</mark>     | Iron in **ferRIC state (Fe3+)**: individuals are **CYANOTIC**<br><br>inherited condition (<mark class="red">Hgb M</mark>)<br>**brownish** blood                                           |
| <mark class="red">Sulfhemoglobin</mark>    | **toxic** to humans, affinity to oxygen is **100x more** than normal<br><br>IRreversible<br>NOT MEASURED in the Cyanmethemoglobin method<br>**mauve-lavender** blood<br>**GREEN PIGMENT** |



## Oxyhemoglobin Dissociation Curve
- N: <mark class="red">Sigmoid Curve</mark>
- Y axis (O2 saturation) = amt. of oxygen attached to HEMOGLOBIN
- X axis (O2 partial pressure) = amt. of oxygen in the BLOOD
- p50 = <mark class="red">26.6 mmHg</mark>; value that saturations 50% of Hemoglobin
![[Pasted image 20240429151253.png]]

|                                          |                                                                                                                                                                                                                                                                                                                                                      |
| ---------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">LEFT</mark> Shift (B)  | <mark class="red">↑ O2 affinity to Hgb</mark><br><mark class="red">↓ O2 deliver to the tissues</mark><br><br><mark class="red">↓ H+, ↑pH</mark><br><mark class="red">↓ 2,3-DPG, CO2</mark><br>abnormal Hgb w/ HIGH O2 affinity (<mark class="red">Hgb F</mark>, <mark class="red">Carboxyhemoglobin</mark>, <mark class="red">Sulfhemoglobin</mark>) |
| <mark class="red">RIGHT</mark> Shift (C) | <mark class="red">↓ O2 affinity to Hgb</mark><br><mark class="red">↑ O2 delivery to the tissues</mark><br><br><mark class="red">↑ H+, ↓ pH</mark><br><mark class="red">↑ 2,3-DPG, CO2</mark><br><mark class="red">exercise, high altitude</mark><br>                                                                                                 |

## Hemoglobin Electrophoresis


|                                            |                                                                                     |
| ------------------------------------------ | ----------------------------------------------------------------------------------- |
| <mark class="red">CELLULOSE ACETATE</mark> | ![[Pasted image 20240429151330.png]]<br><br>pH = <mark class="red">8.4</mark>       |
| <mark class="red">ACID CITRATE</mark>      | ![[Pasted image 20240429151340.png]]<br><br>pH = <mark class="red">6.0 - 6.2</mark> |

# ERYTHROCYTE DESTRUCTION  

|                                                  |                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| ------------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">EXTRA</mark>vascular Hemolysis | - Lysis of RBCs by **macrophages** in the <mark class="red">spleen</mark> and sometimes <mark class="red">liver</mark> or <mark class="red">bone marrow</mark><br>- Represents **majority (90%)** of normal erythrocyte destruction.<br><br>KEY FEATURES<br>- <mark class="red">Microspherocytes</mark><br>- ↑ LD<br>- N to ↓ Haptoglobin<br>- ↑ B1<br>- ↑ urine & fecal urobilinogen<br><br>- Ig<mark class="red">G</mark>                                 |
| <mark class="red">INTRA</mark>vascular Hemolysis | - Lysis of RBCs within the <mark class="red">circulation</mark><br>- Represents only about **10%** of normal erythrocyte destruction<br><br>KEY FEATURES<br>- <mark class="red">Schistocytes</mark><br>- ↑ LD<br>- ↓ Haptoglobin<br>- ↑ Free (plasma) hemoglobin<br>- ↑ urine hemoglobin<br>- ↑ B1 (not frequent, usually EXTRAvascular)<br>- HemosiderinURIA<br><br>- HemoglobinURIA occurs when HAPTOGLOBIN is DEPLETED<br>- Ig<mark class="red">M</mark> |



# DISEASES OF ERYTHROCYTES

## Classification of Anemias

> [!NOTE]
> ANEMIA
> - ↑ blood loss
> - impaired RBC production
> - ↑ RBC destruction


```leaflet
id: leaflet-map
image: [[Pasted image 20240105220744.png]]
defaultZoom: 9
width: 80%
```


|                                     |                                                                                                                                                                                                                         |
| ----------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">MICROcytic</mark> | - **Iron Deficiency Anemia**<br>- **Thalassemia**<br>- **Sideroblastic** Anemia<br>- **Lead Poisoning**<br>- **Chronic inflammation**                                                                                   |
| <mark class="red">MACROcytic</mark> | <mark class="red">Megaloblastic</mark><br>- **Vitamin B12 deficiency**<br>- **Folate deficiency**<br><br><mark class="red">Nonmegaloblastic</mark><br>- **Alcoholism**<br>- **Liver disease**<br>- **Hemolytic** anemia |
| <mark class="red">NORMOcytic</mark> | - **Hereditary hemolytic anemia**<br>- **Immune hemolytic anemia**<br>- **AIHA**<br>- **Malaria**<br>- **Hypoproliferative**<br>- **Acute hemorrhage**<br>- **Hemoglobinopathies**<br>- **Systemic** disorders          |


## Microcytic Anemia

| Name                                                                                                                                                                                                                                                                                                   | Pathophysiology                                                                                                                                                                                                                                                                  | Laboratory Findings                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">Iron Deficiency Anemia</mark><br><br>ETIOLOGIES<br>- Excessive loss<br>- Increased requirement<br>- Deficient intake<br>- Defective iron absorption<br><br>strictly ACQUIRED                                                                                                         | Iron is a **major constituent** of hemoglobin and many enzymes                                                                                                                                                                                                                   | <mark class="red">Peripheral Blood</mark><br>- **Microcytosis** and **hypochromia**<br>- **Anisocytosis**, **poikilocytosis** (pencil cells/elliptocytes; target cells), **thrombocytosis**<br><br><mark class="red">Bone Marrow</mark><br>- **Mild erythroid hyperplasia**<br>- Decreased **iron stores**<br><br><mark class="red">Chemistry</mark><br>- **ZPP** ↑<br>- **Serum iron** ↓<br>- **TIBC** ↑<br>- **Iron saturation** ↓ (10%)<br>- **Ferritin** ↓<br>- **SSTR** (Serum Soluble Transferrin Receptor) ↑                                                                                                   |
| <mark class="red">Thalassemia</mark><br><br>ETIOLOGY<br>- Genetic (QUANtitative decrease in globin producion)<br>- structurally normal<br><br>- Incidence parallels malaria belt<br><br>strictly GENETIC                                                                                               | **<mark class="red">Alpha thalassemia</mark>**: Decreased production of alpha chains results in formation of **hemoglobin tetramers**<br><br>**<mark class="red">Beta thalassemia</mark>**: Decreased production of beta chains results in increased **HbA2** and **HbF** levels | <mark class="red">Peripheral Blood</mark><br>- <mark class="red">Increased RBC count</mark> (other forms of MICROcytic are ↑)<br>- Low MCV (degree depends on the type of Thalassemia: beta (55 - 65 fL); alpha (65 - 75 fL)<br>- Low hematocrit and hemoglobin<br>- **Anisocytosis**, **poikilocytosis**, nucleated RBCs, basophilic stippling, polychromasia, **target cells**<br><br><mark class="red">Other Findings</mark><br>- Massive **bone marrow expansion** (bone changes and SKELETAL deformities)<br>- **Splenomegaly** and **hypersplenism** (common)<br>- **Iron overload** (transfusion-dependent px) |
| <mark class="red">Sideroblastic Anemia</mark><br><br>ACQUIRED or INHERITED<br><br>Acquired<br>- Myelodysplastic syndromes<br>- Medications<br>- Irradiation<br>- Copper deficiency<br><br>if INHERITED, usually **X-linked** condition<br><br>[[Hema (ASCPi)#^qd13m5\|Lead Poisoning]]<br><br><br><br> | **Enzymatic defect in HEME synthesis** results in **excess iron accumulation** in mitochondria and developing RBCs                                                                                                                                                               | <mark class="red">Peripheral Blood</mark><br>- **Hypochromic** RBCs (if Inherited)<br>- **Dimorphic** population of RBCs (if Inherited)<br>- **Basophilic stippling** and **Pappenheimer bodies**<br><br>- Macrocytic (if Acquired)<br><br><mark class="red">Bone Marrow</mark><br>- **Erythroid hyperplasia**<br>- Increased **iron stores**<br>- Increased **ringed sideroblasts**<br><br><mark class="red">Chemistry</mark><br>- **Serum iron** ↑<br>- **TIBC** ↓<br>- **Iron saturation** ↑<br>- **Ferritin** ↑ (iron is not utilized)                                                                            |
| <mark class="red">Chronic Inflammation</mark><br><br>common cause of anemia in HOSPITALIZED px<br><br>differentiate between IDA vs Chronic inflam                                                                                                                                                      | **Defective iron utilization** mediated by **HEPCIDIN** (APR)                                                                                                                                                                                                                    | <mark class="red">Peripheral Blood</mark><br>- **NORMOcytic** or **microcytic** anemia<br>- **Anisocytosis**<br>- Decreased reticulocyte count<br><br><mark class="red">Bone Marrow</mark><br>- Increased **iron stores**<br><br><mark class="red">Chemistry</mark><br>- **Serum iron** N or ↓<br>- **TIBC** N or ↓<br>- **Iron saturation** >15%<br>- **Ferritin** N to ↑<br>- **SSTR** N                                                                                                                                                                                                                            |

^5xq6dz

> [!NOTE]
> - $ ALPHA THALASSEMIA  (normal (aa/aa))
> 	- Silent carrier (a+/a) (\_a/aa) - Heterozygous condition; only 1 gene is deleted
> 	- Alpha Thalassemia Minor - 2 genes are deleted
> 		- (a+/a+) (\_a/\_a) = Homozygous
> 		- (ao/a) (\_\_/aa) = Heterozygous
> 	- Hemoglobin H disease -  3 genes are deleted; Heterozygous;
> 		- (ao/a+) (\_\_/\_a)
> 		- Hgb H = (beta 4)
> 	- Bart's Hydrops Fetalis = 4 genes are deleted; Homozygous
> 		- (ao/ao) (\_\_/\_\_)
> 		- Bart's Hgb (gamma 4) -  incompatible w/ life
> - $ BETA THALASSEMIA
> 	- Bo/Bo (NO PRODUCTION of beta chain) or B+/B+ (marked decrease in production) = Homozygous/Major/Cooley's anemia; severe macrocytic hypochromic anemia
> 	- Bo/B+ or Bo/B or B+/B = Heterozygous/Minor; no B chains are produced; no to variable anemia

> [!NOTE] Lead Poisoning
> - similar findings w/ sideroblastic anemia
> - coarse basophilic stippling
> - inhibits enzymes in the hemoglobin synthesis pathway (Ferrochelatase & ALA synthase) ^qd13m5

## Macrocytic Anemia



> [!info] Nonmegaloblastic
> -  Alcoholism (direct damage to RBC precursors)
> - Liver dss (↑ RBC membrane lipids that accumulate in RBCs, increasing the surface area relative to volume)
> - Hemolytic anemia (stimulate EPO production, thus EARLY RELEASE of Reticulocyte from the bone marrow)
> 
> > [!important] NOTE (vs MEGALOBLASTIC)
> > - RBCs are round
> > - Polychromasia
> > - NO HYPERsegmented neutrophil
> > - NO other megaloblastic change ^e3p28l

> [!NOTE]
> Megaloblasts (large RBCs precursors w/ basophilic cytoplasm and fine particulate chromatin; NUCLEAR-CYTOPLASMIC ASYNCHRONY seen)

### CAUSES Of Folate and Vitamin B12 Deficiency


|                          | <mark class="red">Folate</mark> Deficiency | <mark class="red">Vitamin B12</mark> Deficiency                                                                     |
| ------------------------ | ------------------------------------------ | ------------------------------------------------------------------------------------------------------------------- |
| Diet                     | **Common** (Alcoholism)                    | Rare (strict vegetarians)                                                                                           |
| Malabsorption            | **Sprue**                                  | **Pernicious anemia**, **Postgastrectomy**, **Pancreatic insufficiency**, **Crohn disease**, **D. latum infection** |
| Increased demand         | **Pregnancy**, **Hemolysis**               | **Pregnancy**, **Hemolysis**                                                                                        |
| Drugs                    | <mark class="red">Methotrexate</mark>      | <mark class="red">Dilantin</mark>                                                                                   |
| Inherited #table-column  | None                                       | **Transcobalamin II deficiency**                                                                                    |

^qk9x3t

### MANIFESTATIONS Of Folate and Vitamin B12 Deficiency

|                         | <mark class="red">Folate</mark> Deficiency                                                                                                                                      | <mark class="red">Vitamin B12</mark> Deficiency                                                                      |
| ----------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------- |
| Peripheral blood        | **Oval macrocytosis**, **Hypersegmented neutrophils**, **Pancytopenia (when ==severe==)**, **Anisopoikilocytosis (==variable==)**<br><br>[[Hema (ASCPi)#^e3p28l\|vs NONMEGALO]] | <                                                                                                                    |
| Bone marrow             | **Hypercellularity**, **megaloblastic** changes, **Erythroid hyperplasia** with LEFT shift                                                                                      | <                                                                                                                    |
| Chemistry #table-column | ↑ LD (bec highest increase in LD is seen in Megaloblastic type of anemia), ↑ B1<br>↓ serum & RBC FOLATE<br>↑ urinary <mark class="red">formimiglutamic acid (FIGLU)</mark>      | ↑ LD, ↑ B1<br>↓ serum B12, ↓ RBC folate (seen in 2/3 cases)<br>↑ urinary <mark class="red">methylmalonic acid</mark> |

^ja0442

## RBC Inclusions

| Inclusion                                                                    | Appearance in SUPRAVITAL STAIN                                                                 | Appearance in WRIGHT STAIN                                                                      | Inclusion Composed of                                                 | Associated Diseases/Conditions                                                                                                                                                      |
| ---------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------- | --------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">Diffuse basophIlia</mark><br><br>Fine Basophilic Stippling | Dark blue granules and **filaments** in cytoplasm (seen in **reticulocytes**)                  | **Bluish tinge** throughout cytoplasm; also called **polychromasia** (seen in eryt**h**rocytes) | <mark class="red">RNA</mark>                                          | **Hemolytic anemia** <br>**After treatment for iron**, **vitamin B12**, or **folate deficiency**                                                                                    |
| <mark class="red">Basophilic stippling</mark><br><br>coarse                  | Dark blue-purple, fine or **coarse punctate granules** distributed throughout cytoplasm        | Dark blue-purple, fine or coarse **punctate granules** distributed throughout cytoplasm         | <mark class="red">Precipitated RNA</mark>                             | **Lead poisoning** <br>**Thalassemia** <br>**Hemoglobinopathies** <br>**Megaloblastic anemia** <br>**Myelodysplastic syndrome**                                                     |
| <mark class="red">Howell-Jolly body</mark>                                   | Dark blue-purple dense, **round granule**; usually **one per cell**; occasionally multiple     | Dark blue-purple dense, **round granule**; usually **one per cell**; occasionally multiple      | <mark class="red">DNA (nuclear fragment)</mark>                       | **Hyposplenism** <br>**Postsplenectomy** <br>**Megaloblastic anemia** <br>**Hemolytic anemia** <br>**Thalassemia** <br>**Myelodysplastic syndrome**                                 |
| <mark class="red">Heinz body</mark>                                          | **Round**, dark blue-purple granule attached to inner RBC membrane                             | <mark class="red">NOT VISIBLE</mark>                                                            | <mark class="red">Denatured hemoglobin</mark>                         | **Glucose-6-phosphate dehydrogenase deficiency** <br>**Unstable hemoglobins** <br>**Oxidant drugs/chemicals**                                                                       |
| <mark class="red">Pappenheimer bodies</mark><br><br>(+) Prussian blue stain  | **Irregular clusters** of small, light to dark blue granules, often **near periphery** of cell | Irregular clusters of small, light to dark blue granules, often **near periphery of cell**      | <mark class="red">Iron</mark>                                         | **Sideroblastic anemia** <br>**Hemoglobinopathies** <br>**Thalassemias** <br>**Megaloblastic anemia** <br>**Myelodysplastic syndrome**<br>**Hyposplenism** <br>**Post-splenectomy** |
| <mark class="red">Cabot ring</mark>                                          | **Rings** or **figure-eights**                                                                 | **Blue rings** or **figure-eights**                                                             | <mark class="red">Remnant of mitotic spindle</mark>                   | **Megaloblastic anemia**<br>**Myelodysplastic syndromes**                                                                                                                           |
| <mark class="red">Hb H</mark>                                                | Fine, evenly dispersed, dark blue granules; imparts **"golf ball" appearance** to RBCs         | <mark class="red">NOT VISIBLE</mark>                                                            | Precipitate of <mark class="red">β-globin chains</mark> of hemoglobin | **Hb H disease**                                                                                                                                                                    |

^bgxymc

# RBC Anomalies


| RBC Abnormality                                 | Cell Description                                          | Commonly Associated Disease States                                                                                                          |
| ----------------------------------------------- | --------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">Anisocytosis</mark>           | Abnormal variation in **RBC volume or diameter**          | **Hemolytic**, **megaloblastic**, **iron deficiency anemia**                                                                                |
| <mark class="red">Macrocyte</mark>              | Large RBC (**>8 µm** in diameter), **MCV >100 fL**        | **Megaloblastic anemia** <br>**Myelodysplastic syndrome** <br>**Chronic liver disease** <br>**Bone marrow failure** <br>**Reticulocytosis** |
| <mark class="red">Oval macrocyte</mark>         | Large oval RBC                                            | **Megaloblastic anemia**                                                                                                                    |
| <mark class="red">Microcyte</mark>              | Small RBC (**<6 µm** in diameter), **MCV <80 fL**         | **Iron deficiency anemia** <br>**Anemia of chronic inflammation** <br>**Sideroblastic anemia** <br>**Thalassemia/Hb E** disease and trait   |
| <mark class="red">Poikilocytosis</mark>         | Abnormal variation in RBC **shape**                       | **Severe anemia**; certain shapes helpful diagnostically                                                                                    |
| <mark class="red">Spherocyte</mark>             | Small, round, dense RBC with **no central pallor**        | **Hereditary spherocytosis** <br>**Immune hemolytic anemia**<br>**Extensive burns (along with ==schistocytes==)**                           |
| <mark class="red">Elliptocyte, ovalocyte</mark> | Elliptical (**cigar-shaped**), oval (**egg-shaped**), RBC | **Hereditary elliptocytosis or ovalocytosis**<br>**Iron deficiency anemia** <br>**Thalassemia major** <br>**Myelophthisic anemias**         |

^jzzn8f




|                                                     |                                                                                                                                                                                       |                                                                                                                                                                                                       |
| --------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">Stomatocyte</mark> ☺              | RBC with **slit-like area** of central pallor <br>                                                                                                                                    | **Hereditary stomatocytosis**<br>**Rh deficiency syndrome (<mark class="red">Rh null</mark>)**<br>**Acquired stomatocytosis (==liver disease==, ==alcoholism==)**                                     |
| <mark class="red">Sickle cell</mark>                | Thin, dense, **elongated** RBC **pointed** at each end; may be **curved**                                                                                                             | **Sickle cell anemia**<br>**Sickle cell–β-thalassemia**                                                                                                                                               |
| <mark class="red">Hb C crystal</mark>               | **Hexagonal** crystal of dense hemoglobin formed within the RBC membrane                                                                                                              | **Hb C disease**                                                                                                                                                                                      |
| <mark class="red">Hb SC crystal</mark>              | **Fingerlike or quartz-like** crystal of dense hemoglobin **protruding** from the RBC membrane                                                                                        | **Hb SC disease**                                                                                                                                                                                     |
| <mark class="red">Target cell (codocyte)</mark>     | RBC with **hemoglobin concentrated in the center** and around the **periphery** resembling a target                                                                                   | **Liver disease** <br>**Hemoglobinopathies**<br>**Thalassemia**                                                                                                                                       |
| <mark class="red">Schistocyte (schizocyte)</mark>   | **Fragmented** RBC due to **rupture in the peripheral circulation**                                                                                                                   | **MICROangiopathic hemolytic anemia**\* (along with microspherocytes)<br>**MACROangiopathic hemolytic anemia**\**<br>**Extensive burns** (along with microspherocytes)                                |
| <mark class="red">Helmet cell (keratocyte)</mark>   | RBC fragment in shape of a helmet                                                                                                                                                     | Same as **schistocyte**                                                                                                                                                                               |
| <mark class="red">Folded cell</mark>                | RBC with **membrane folded over**                                                                                                                                                     | **Hb C disease** <br>**Hb SC disease**                                                                                                                                                                |
| <mark class="red">Acanthocyte (spur cell)</mark>  ☺ | Small, dense RBC with few **irregularly spaced projections** of varying length                                                                                                        | **Severe liver disease (<mark class="red">spur cell anemia</mark>)**<br>**Neuroacanthocytosis (<mark class="red">abetalipoproteinemia</mark>, <mark class="red">McLeod syndrome (Kell null)</mark>)** |
| <mark class="red">Burr cell (echinocyte)</mark> ☺   | RBC with **blunt or pointed, short projections** that are usually **evenly spaced** over the surface of cell; present in all fields of blood film but in variable numbers per field\* | **Uremia** (if not found, find Kidney failure) <br>**Pyruvate kinase deficiency**                                                                                                                     |
| <mark class="red">Teardrop cell (dacrocyte)</mark>  | RBC with a **single pointed extension** resembling a **teardrop** or **pear**                                                                                                         | **Primary myelofibrosis** <br>**Myelophthisic anemia**<br>**Thalassemia** <br>**Megaloblastic anemia**<br><br><mark class="red">3Ms</mark>                                                            |

^6nxec3





|                                      |                                                    |                                                                                                                                                                                                                                                                                                                                    |
| ------------------------------------ | -------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| ![[Pasted image 20240429160540.png]] | <mark class="red">Normal peripheral smear</mark>   | Erythrocytes appear as **circular, homogeneous disks** of nearly uniform size, ranging from **6–8 µm** in diameter, with central pallor not exceeding more than one third of the cell. On average, the red cells are **approximately the same size as the nucleus of a <br>==small lymphocyte==** (<mark class="red">500x</mark>). |
| ![[Pasted image 20240429160601.png]] | <mark class="red">Macrocytes</mark>                | Red cells are larger and thicker, stain deeply, and **lack central pallor** (<mark class="red">500x</mark>).                                                                                                                                                                                                                       |
| ![[Pasted image 20240429160629.png]] | <mark class="red">Hereditary elliptocytosis</mark> | Most cells are **elliptocytes**. They are seen in a normal person’s blood, but usually account for **less than 10% of cells**. They are also common in <mark class="red">**iron deficiency anemia**, **myelofibrosis**, **megaloblastic anemia**, and **sickle cell anemia** </mark>(<mark class="red">1000x</mark>).              |
| ![[Pasted image 20240429160802.png]] | <mark class="red">Schistocytes</mark>              | Presence of **cell fragments** is indicative of **hemolysis**. Schistocytes can be seen in several conditions, including <mark class="red">**microangiopathic hemolytic anemia**, **megaloblastic anemia**, **burns**, and **disseminated intravascular coagulation** </mark>(<mark class="red">500x</mark>).                      |
| ![[Pasted image 20240429160811.png]] | <mark class="red">Echinocytes</mark>               | Regularly contracted cells with **sharp ends**; may occur as an artifact during **film preparation** or as the result of **hyperosmolarity** or **decreased adenosine triphosphate** due to several causes (<mark class="red">1000x</mark>).                                                                                       |
| ![[Pasted image 20240429160823.png]] | <mark class="red">Microcytic hypochromic</mark>    | Red cells in <mark class="red">**iron deficiency anemia**</mark>. Red cells are hypochromic—the amount of hemoglobin per cell is decreased, and the **central pale area becomes larger (==more than one third==)** (<mark class="red">500x</mark>).                                                                                |
| ![[Pasted image 20240429160844.png]] | <mark class="red">Hereditary spherocytosis</mark>  | Spherocytes are **nearly perfectly round** in shape, **smaller** than normal red cells, and lack central pallor (**hyperchromic**) (<mark class="red">1000x</mark>).                                                                                                                                                               |
| ![[Pasted image 20240429161054.png]] | <mark class="red">Target cells</mark>              | Red cells with **thin membrane**, peripheral rim of hemoglobin (Hb), and dark, central, Hb-containing area. They are frequently seen in <mark class="red">**Hb C disease**, in **hypochromic anemia**, and in **liver disease**</mark> (<mark class="red">1000x</mark>).                                                           |
| ![[Pasted image 20240429161112.png]] | <mark class="red">Acanthocytes</mark>              | **Irregularly spiculate**d cells with **bulbous and rounded end**s, frequently seen in <mark class="red">**ABETALIPOPROTEINEMIA**</mark> or certain cases of **liver disease** (<mark class="red">1000x</mark>).                                                                                                                   |
| ![[Pasted image 20240429161124.png]] | <mark class="red">Artifact</mark>                  | **Tiny pits or bubbles** in the red cells. They can be caused by a small amount of **water** contaminating the Wright’s stain or by **insufficient slide drying** (<mark class="red">500x</mark>).<br><br><mark class="red">Moth-eaten appearance</mark>                                                                           |

> [!NOTE] Hereditary ELLIPTOcytosis
> - normal pbs (<10% elliptocyte)
> - autosomal DOMINANT
> - diagnosed when >25% elliptocytes
> - Forms
> 	- Common (elliptocytes, asymptomatic to severe)
> 	- Spherocytic HE (spherocytes + elliptocytes)
> 	- Stomatocytic HE (aka Southeast Asian Ovalocytosis; resistance to P. vivax)
> - Defect of Hereditary ELLIPTOcytosis (Spectrin & Band 4.1)
> - (Hereditary PYROpoikilocytosis) Severe subtype of HE; autosomal RECESSIVE

> [!NOTE] Hereditary SPHEROcytosis
> - Defects of Hereditary SPHEROcytosis (Ankyrin, Band 3, Spectrin)
> - ↑ MCHC (50% of the cases)
> - spherocyte & polychromasia
> - ↑ osmotic fragility
> - negative for DAT
> - ↓ EMA (eosin-5-maleimide) binding test, aka Band 3 reduction test

# LEUKOCYTE DISORDERS


## Summary of Leukocyte Disorders

|                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| ----------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">NON-malignant Granulocytic</mark> Disorders                             | <mark class="red">QUANtitative</mark><br>1. **Physiologic PSEUDOneutrophilia** (Neutrophilia = >7500/uL)<br>2. **Pathologic Neutrophilia** (toxic changes (granulations, vacuolations, Dohle bodies))<br>3. **Neutrophilic Leukemoid Reaction** (Left shift; ↑ LAP score)<br>4. **Leukoerythroblastic Reaction**<br><br><mark class="red">QUALitative</mark><br>5. <mark class="red">**Functional Disorders**</mark><br>   - **Chronic Granulomatous Disease**<br>   - **Chediak-Higashi Syndrome**<br>6. <mark class="red">**Nuclear Abnormalities**</mark><br>   - **Hypersegmentation** (Megaloblastic Anemia)<br>   - **Hyposegmentation (==Pelger-Huet== and ==Pseudo Pelger-Huet Anomaly==)** -  lobulations  <2<br>7. <mark class="red">**Inherited Cytoplasmic Anomalies**</mark><br>   - **May-Hegglin Anomaly**<br>   - **Alder-Reily Anomaly** |
| <mark class="red">Monocytic</mark> Disorders                                              | 1. **Gaucher’s disease** (glucocerebrosidase deficiency; crumpled tissue paper appearance)<br>2. **Niemann-Pick disease** )sphingomyelinase deficiency; foamy appearance)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| <mark class="red">Non-malignant Lymphocytosis</mark> Associated with **Viral Infections** | 1. **Infectious Mononucleosis** (EBV; reactive T lymphocytes; heterophile Ab (+))<br>2. **Cytomegalovirus** (similar to IM; most common TRANSPLACENTALLY transmitted infection; NO reactive lymphocytes; heterophile Ab (-))<br>3. **Infectious Lymphocytosis** (Adenovirus, Coxsackie A; no reactive lymphocytes)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| <mark class="red">Malignant Leukocytic</mark> Disorders                                   | 1. **Acute Lymphoproliferative Disorders**<br>2. **Acute Myeloproliferative Disorders**<br><br>3. <mark class="red">**Chronic Leukemias**</mark><br>   - **Chronic Myelogenous Leukemia**<br>   - **Essential Thrombocythemia**<br>   - **Polycythemia Vera**<br>   - **Chronic Idiopathic Myelofibrosis**<br>   - **Chronic Lymphocytic Leukemia**<br>   - **Hairy Cell Leukemia**<br>   - **Prolymphocytic Leukemia**<br>4. <mark class="red">**Other Lymphoid Malignancies**</mark><br>   - **Multiple Myeloma**<br>   - **Waldenstrom’s Macroglobulinemia**<br>   - **Hodgkin's Lymphoma**<br>   - **Non-Hodgkin's Lymphoma**<br>   - **Mycosis Fungoides**<br><br>5. **Myelodysplastic Syndromes**                                                                                                                                                   |


|                                                                                                                                                                                                                                                                       |                                                        |
| --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------ |
| - ineffective intracellular destruction of ingested organisms<br>- defect in the respiratory burst (used to kill the organism)<br>- MORPHOlogically normal, FUNCTIONALLY ABnormal<br>- deficiency in NADPH oxidase (important for WBC to mount the respiratory burst) | <mark class="red">Chronic Granulomatous Disease</mark> |
| - abnormal fusion of primary & secondary granules<br>- due to a mutation in the lysosomal trafficking regulatory gene (CHS1 / LYST)<br>- gigantic granules that are peroxidase (+)<br>- MORPHOlogically ABnormal, FUNCTIONALLY ABnormal                               | <mark class="red">Chediak-Higashi Syndrome</mark>      |



|                                                                                                                                                   |                                              |
| ------------------------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------- |
| - large, crystalline, dohle-like inclusions<br>- giant platelets, ↓ PLT count (giants no longer counted as PLT), bleeding<br>- MYH9 gene mutation | <mark class="red">May-Hegglin Anomaly</mark> |
| - large azurophilic granules which contains DEGRADED MUCOPOLYSACCHARIDES<br>- Hunter, Hurler, San Filippo syndrome                                | <mark class="red">Alder-Reily Anomaly</mark> |




|                                                                                                                                                  |                                  |
| ------------------------------------------------------------------------------------------------------------------------------------------------ | -------------------------------- |
| - cellular morphology<br>- cytochemical staining<br>- >30% blasts BM & PBS                                                                       | <mark class="red">FAB</mark><br> |
| - standard for diagnosis<br>- immunologic probes<br>- cytogenetics<br>- molecular abnormalities<br>- clinical syndrome<br>- >20% blasts BM & PBS | <mark class="red">WHO</mark>     |



 


|                                      |                                                                                                                                                                                                        |
| ------------------------------------ | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| ![[Pasted image 20240429170247.png]] | A <mark class="red">neutrophil with toxic granulation</mark> is pictured, along with two bands. **Basophilic inclusions (==Döhle bodies==)** are present as well. (<mark class="red">x1000</mark>)     |
| ![[Pasted image 20240429170257.png]] | The <mark class="red">Alder-Reilly anomaly</mark> may be found in **healthy** individuals or in those **mucopolysaccharidoses**, in which granules are metachromatic (<mark class="red">x1000</mark>). |
| ![[Pasted image 20240429170313.png]] | <mark class="red">Chédiak-Higashi</mark> neutrophils and lymphocytes with **large granules** (<mark class="red">x1000</mark>).                                                                         |
| ![[Pasted image 20240429170324.png]] | <mark class="red">Auer rods</mark> vary from prominent, as in this cell, to thin and delicate.                                                                                                         |
| ![[Pasted image 20240429170334.png]] | An **abnormal macrophage** in <mark class="red">Gaucher’s disease</mark> (<mark class="red">x1000</mark>)                                                                                              |
| ![[Pasted image 20240429170351.png]] | <mark class="red">May-Hegglin anomaly</mark>, showing **Döhle-like inclusions** (<mark class="red">x1000</mark>).                                                                                      |
| ![[Pasted image 20240429170401.png]] | <mark class="red">Inherited Pelger-Huët anomaly</mark> (<mark class="red">x1000</mark>).                                                                                                               |
| ![[Pasted image 20240429170412.png]] | <mark class="red">Infectious mononucleosis</mark>, showing a **large activated lymphoid cell** in the blood (<mark class="red">x1000</mark>).                                                          |
| ![[Pasted image 20240429170422.png]] | <mark class="red">Sézary cell</mark> in the blood, along with a neutrophil (<mark class="red">x1000</mark>).                                                                                           |
| ![[Pasted image 20240429170434.png]] | An **abnormal macrophage** in <mark class="red">Niemann-Pick disease</mark> (<mark class="red">x1000</mark>)                                                                                           |

## Acute MYELOID Leukemia

- AML with **recurrent genetic abnormalities**
- AML with **myelodysplasia related changes**
- **Therapy-related myeloid neoplasms**
- AML, not otherwise specified

> [!NOTE]
> - represents MOST leukemia in ADULTS & INFANTS
> - ↑ WBC ct (due to BLASTS); variable (depending on the type of leukemia)
> - NORMOcytic, NORMOchromic
> - ↓ PLT ct

> [!NOTE]
> q = long arm
> p = short arm
> 1st digit = region
> 2nd digit = band
> 1st digit after decimal = subband
> 
> q22 (long arm of region 2, band 2)
> q22.1 (long arm of region 2, band 2, subband 1)

| Genetic abnormality                                                  | Morphology                                                                                                                                                                | Cytochemistry                                                                   | Major immunophenotype                                                                                                | Special notes                                                      |
| -------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------ |
| <mark class="red">t(8;22)</mark><br><br>(q22;q22.1)                  | **Neutrophil lineage** maturation; **Auer rods**; **neutrophilic dysplasia**                                                                                              | **MPO POSITIVE**                                                                | MPO, CD 34, CD13, HLA-DR positive; sometimes CD56 & CD19 positive                                                    | resemble M2 morphology                                             |
| <mark class="red">in(16)</mark><br><br>(p13.1;q22)<br>or<br>t(16;16) | **Neutrophil** and **monocytic** maturation; increased and abnormal **eosinophils** in BM                                                                                 | **MPO POSITIVE**, **NSE POSITIVE**; eosinophils positive with naphthyl esterase | CD34, CD13, CD33, CD14, CD2, CD11b, CD11c, CD64, lysozyme positive                                                   | resemble M4 morphology                                             |
| <mark class="red">t(15;17)</mark><br><br>(q22;q12)                   | **Hypergranular variant**, Abnormal promyelocytes, **<mark class="red">Bundles of Auer rods</mark>**, **Microgranular variant**, **Bilobed** nuclei, Granules NOT visible | **MPO STRONGLY POSITIVE**                                                       | CD33, CD13 positive; CD15, HLA-DR both weakly positive; CD2, CD34 may be positive in microgranular variant.          | associated w/ APL/M3<br><br>faggot cells<br>most associated w/ DIC |
| <mark class="red">t(9;11)</mark><br><br>(p21.3;q23.3)                | **Monoblast** and **promonocytes** predominate                                                                                                                            | <mark class="red">**MPO negative**, **NSE POSITIVE**</mark>                     | CD33, CD64, CD4, HLA-DR, CD11b, CD14, lysozyme positive                                                              | may include DIC<br>extramedullary tissue infiltration              |
| <mark class="red">t(6;9)</mark><br><br>(q23;q34.1)                   | Monocytic component may or may not be seen; **basophilia** and **multilineage dysplasia** common                                                                          | **MPO POSITIVE** in myeloblast, **NSE POSITIVE** in monocytic cells             | MPO, CD13, CD33, CD38, HLA-DR consistently positive; CD117, CD34, CD15 may be positive; CD64 positive in some cases. | often resembles M1 or M4 morphology                                |
| <mark class="red">inv(3)</mark><br><br>t(3,3)                        | **Multilineage dysplasia** (especially with platelets and megakaryocytes) in PB and BM                                                                                    | Dependent on predominate cell type                                              | **CD13**, **CD33**, **HLA-DR**, **CD34**, **CD38** positive; subsets may be **CD41**, **CD61** positive              | often resembles M1, M4 or M7                                       |
| <mark class="red">t(1;22)</mark><br><br>(p13.3;q13.3)                | **Megaryoblasts** and **micromegakaryocytes**                                                                                                                             | **MPO negative** (only (+) if affected are granulocytic and monocytic series)   | **CD41**, **CD42b**, **CD61**, **CD13**, **CD33** positive                                                           |                                                                    |

^ms86kr

## AML not otherwise specified (NOS)

| Subgroup                                                                                                   | Morphology                                                                                                                                | Cytochemistry                                                     | Major immunophenotype                                                                                        | Special notes                                                          |
| ---------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------ | ---------------------------------------------------------------------- |
| M0<br><br><mark class="red">AML w/ minimal differentiation</mark>                                          | NO EVIDENCE myeloid differentiation or maturation                                                                                         | MPO negative                                                      | CD **34**, **HLA-DR**, CD **13**, CD **33**, CD **117**                                                      | Diagnosis requires immunophenotyping                                   |
| M1<br><br><mark class="red">AML w/o maturation</mark>                                                      | Evidence of **myeloid differentiation**, but NO MATURATION                                                                                | MPO POSITIVE (at least 3% - staining intensity for MPO to be pos) | CD **13**, CD **33**, CD **34**, CD **117**, **HLA-DR** positive                                             | Auer rods on cytoplasmic granules may be present                       |
| M2<br><br><mark class="red">AML w/ maturation</mark>                                                       | ≥ 20% blasts in PB or BM;<br>all stages of neutrophils<br>(at least 10%)                                                                  | MPO POSITIVE (at least 3%)                                        | CD **13**, CD **33**, CD **117**, **HLA-DR**, CD **15** positive; VARIABLE expression of HLA-DR, CD34        | ^                                                                      |
| M4<br><br><mark class="red">Acute MyeloMONOcytic Leukemia</mark>                                           | Both **neutrophil** and **monocyte** precursors present                                                                                   | MPO POSITIVE, NSE POSITIVE                                        | CD **13**, CD **33**, CD **14**, CD **4**, CD **11b**, CD **64**, **lysozyme** all positive                  | Often responds to treatment                                            |
| <mark class="red">Acute MonoBLASTic L</mark> (M5a)<br><br><mark class="red">Acute MonoCYTIC L</mark> (M5b) | **Monoblasts**, **promonocytes**, **monocytes** predominate                                                                               | MPO negative, NSE POSITIVE                                        | CD **13**, CD **33**, CD **117** variable; CD **14**, CD **4**, CD **11b**, CD **64**, **lysozyme** positive | characterized by TIssue infiltrates, CNS involvement, Hemophagocytosis |
| M6<br><br><mark class="red">Acute Erythroid Leukemia</mark>                                                | **≥ 80% immature ERYTHROID precursors** with at least **30% protherythroblasts**; **myeloblasts < 20%**; **dysplasia** in erythroid cells | **MPO POSITIVE** in myeloblasts<br>PAS (+)                        | **Glycophorin A (CD 235)**: CD<mark class="red">34</mark>, CD<mark class="red">71</mark> positive            | Rare subgroup of AML<br>Poor prognosis                                 |
| M7<br><br><mark class="red">Acute Megakaryoblastic Leukemia</mark>                                         | **≥20% blasts** with at least **50% megakaryoblasts**; cytoplasmic blebs                                                                  | **MPO negative**, **NSE POSITIVE** (acetate substrate)            | CD<mark class="red">41</mark> and/or CD<mark class="red">61</mark>, CD **13**, CD **33** positive            | characterized by Cytopenia, w/ or w/o thrombocytopenia<br>             |
| <mark class="red">Acute Basophilic Leukemia</mark>                                                         | **Basophilic** precursor                                                                                                                  | **Metachromatic positivity** with toluidine blue                  | CD **13**, CD **33**, CD **34**, **HLA-DR** positive; CD **117** NEGATIVE                                    | very rare (<10% AML)<br>Hyperhistaminemia (culprit of symptoms)        |
| <mark class="red">Acute Panmyelosis w/ Myelofibrosis</mark>                                                | **Blasts** increased; **DYSPLASIA in neutrophils and platelets**                                                                          | **MPO POSITIVE**                                                  | CD **13**, CD **33**, CD **117** positive; CD **41**, CD **61** VARIABLE                                     | Marked PB pancytopenia<br>BM panmyelosis w/ fibrosis                   |

^8r4n2x

> [!NOTE]
> CD41 & 61 (glycoproteins found on the surface of platelets)
> CD41 (main component Gp2b3A)
> CD61 (complexes w/ 41 to form Gp2b3a)

> [!NOTE] MPO (Myeloperoxidase)
>  present in the granules of myeloid series (granulocytes, monocytes)

> [!NOTE] NSE (Non-specific esterase) -  monocytes
> - alpha naphthyl ACETATE
> - alpha naphthyl BUTYRATE ^m3yd7a

> [!NOTE] SE (Specific esterase) - granulocytes
> - Naphthol AS-D Choloroacetate esterase

## Myelodysplastic Syndromes

Myeloid neoplasms characterized by **ineffective hematopoiesis** that displays as **cytopenias**, **dyspoiesis** in at least 1 of the major myeloid lineages, and **increased risk of developing into AML**.


> [!NOTE] Title
> usually seen in OLDER adults
> seen in YOUNG adults due to secondary (chemotherapy, exposure to radiation, benzene, inherited bone marrow failure eg. Fanconi Anemia)

> [!NOTE] Lab Findings
> Hypercellular BM
> <20% blasts
> many dysplastic changes affecting each cell lineage both in PBS & BM 

> [!NOTE] Dysplastic changes (Myeloid Lineage)
> - DysERYTHROpoeisis (RBC)
> 	- Anisocytosis, Poikilocytosis
> 	- Basophilic stipplings
> 	- Irregular cytoplasmic staining
> 	- Ringed sideroblasts
> - DysGRANULOpoeisis (WBC)
> 	- Hypogranulation/abnormal granulation
> 	- Pseudo-Pelger Huet Anomaly
> 	- Hypersegmentation
> 	- Auer rods
> - DysMEGAKARYOCYTOpoeisis (PLT)
> 	- MICROmegakaryocytes
> 	- HYPOgranulation, large abnormal granules
> 	- Giant platelets
> 	- Functional abnormalities

### WHO CLASSIFICATION OF MYELODYSPLASTIC SYNDROMES

> [!NOTE] WHO Scheme (basis of classification for MS)
> - degree of cytopenia & dysplasia
> - CYTOPENIA
> 	- Hgb <10g/dL (<100g/L)
> 	- PLT ct <100 x 103/uL (100 x 109/L)
> 	- Absolute Neutrophil ct <1800/uL (<1.8x109/L)
> 	- Peripheral blood monocytes <1000/uL (<1.0 x109/L)
> - percentage of blasts in the peripheral blood & BM
> - percentage of RINGED SIDEROBLASTS in the BM

| TYPE                                                                                 | <mark class="red">PERIPHERAL BLOOD</mark>                                                                                         | <mark class="red">BONE MARROW</mark>                                                                                                   |
| ------------------------------------------------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------- |
| MDS with <mark class="red">single lineage dysplasia</mark>                           | **Anemia** or **thrombocytopenia** or **neutrophilia** <br>NO BLASTS (<1%) OR AUER RODS <br>No monocytosis (1000/μL[1.0x10⁹/L])   | **Unilineage dysplasia** <br>**<5% blasts** and **NO AUER RODS** <br>**≤15% ringed sideroblasts**                                      |
| MDS with <mark class="red">SINGLE lineage dysplasia and **RING SIDEROBLASTS**</mark> | **Anemia** + **dimorphic RBCs** and **Pappenheimer bodies** <br>No blasts (<1%) Auer rods <br>No monocytosis (1000/μL[1.0x10⁹/L]) | **Dysplastic erythroids** **<5% blasts** and **NO AUER RODS** <br>**\>15% ringed sideroblasts**                                        |
| MDS with <mark class="red">MULTILINEAGE dysplasia</mark>                             | **Bi- or pancytopenia** <br>**<1% blasts** <br>No Auer rods                                                                       | **<5% blasts** and **NO AUER RODS**<br>**Dysplasia** in >10% of >1 cell line <br>**==≤15%== ringed sideroblasts**                      |
| MDS with <mark class="red">MULTIlineage dysplasia and **RINGED SIDEROBLASTS**</mark> | **Bi- or pancytopenia** <br>**<1% blasts** <br>**NO AUER RODS**                                                                   | **<5% blasts** and **NO AUER RODS** <br>**Dysplasia** in >10% of >1 cell line <br>**==\>15%== ringed sideroblasts**                    |
| MDS with <mark class="red">EB</mark> <br>MDS- **EB1** <br>MDS- **EB2**               | **Bi- or pancytopenia** <br>**<5% blasts**, **NO AUER RODS** <br>5%-19% blasts or Auer rods                                       | Dysplasia <br>5%-9% blasts, no Auer rods <br>10-19% blasts or Auer rods                                                                |
| MDS with <mark class="red">isolated del (5q)</mark><br><br>favorable prognosis       | **Anemia**, normal to increased platelets <br>**<5% blasts** <br>**NO AUER RODS**                                                 | **Hypolobated megakaryocyte** <br>**<5% blasts** and **NO AUER RODS** <br>Karyotype: **5q- with 1 additional abnormality**, except 7q- |

^z1xt9f


## MDS, UNCLASSIFIED

| TYPE                                                                    | <mark class="red">PERIPHERAL BLOOD</mark>                             | <mark class="red">BONE MARROW</mark>                                                                  |
| ----------------------------------------------------------------------- | --------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------- |
| With <mark class="red">1% blasts</mark>                                 | **<1% blasts**, **NO AUER RODS**, <br>**cytopenia** in 1-3 cell lines | **<5% blasts**, **dysplasia** in 1-3 cell lines                                                       |
| With single lineage dysplasia and <mark class="red">pancytopenia</mark> | **<1% blasts**, **NO AUER RODS**, <br>**cytopenia** in 1-3 cell lines | **<5% blasts**, **dysplasia** in 1 cell line                                                          |
| Based on defining <mark class="red">cytogenetic abnormality</mark>      | **<1% blasts**, **NO AUER RODS** <br>**cytopenia** in 1-3 cell lines  | **<5% blasts**; **15% ringed sideroblasts**; <br>**MDS-defining abnormality**, NO DYSPLASTIC LINEAGES |
| <mark class="red">Refractory cytopenia of childhood</mark>              | **<2% blasts**; **cytopenia** in 1-3 cell lines                       | **<5% blasts**; **dysplasia** in 1-3 cell lines                                                       |

^asngka

## Myeloproliferative Neoplasms

- Group of closely related **malignant** disorders that **result from AUTONOMOUS CLONAL PROLIFERATION of hematopoietic stem cells**.
- Although characterized by abnormal proliferation of **all myeloid** lineages, **1 cell line typically more prominently involved**.

> [!NOTE]
> usually affecting middle-aged or older adults

### LABORATORY FINDINGS IN SELECTED MYELOPROLIFERATIVE NEOPLASMS

| #table-column                                                 | <mark class="red">CML</mark><br><br>- exhibits COMPLETE spectrum of granulocytic series in PBS (all stages seen) | <mark class="red">PV</mark><br><br>- PANCYTOSIS                      | <mark class="red">PM (Primary Myelofibrosis)</mark>                    | <mark class="red">ET (Essential Thrombocytosis)</mark> |
| ------------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------- | ---------------------------------------------------------------------- | ------------------------------------------------------ |
| WBC                                                           | **MARKEDLY elevated** (>50 x 109/L)                                                                              | **MODERATELY elevated** (<30 x 109/L)                                | Variable                                                               | Normal or elevated (<30x109/L)                         |
| Hemoglobin                                                    | Normal or decreased                                                                                              | **Markedly elevated**<br><br><mark class="red">Erythrocytosis</mark> | **Decreased**                                                          | Variable                                               |
| Platelets                                                     | Variable                                                                                                         | Normal or elevated                                                   | Variable                                                               | **Markedly elevated** (>450 x 109/L)                   |
| <mark class="red">PERIPHERAL BLOOD MORPHOLOGIC CHANGES</mark> | <                                                                                                                | <                                                                    | <                                                                      | <                                                      |
| WBC                                                           | **Immature granulocytes**                                                                                        | none                                                                 | **Immature granulocytes**                                              | **Occasional immature granulocytes**                   |
| ^                                                             | **Eosinophilia**, **basophilia**                                                                                 | Occasionally **eosinophils** increase and **basophilia**             | Occasionally **eosinophils** increase and **basophilia**               | **Mild eosinophilia**, **basophilia** possible         |
| RBC                                                           | Normocytic, Normochromic                                                                                         | Normocytic, Normochromic                                             | **<mark class="red">Dacrocytes</mark>**, **nucleated red blood cells** | Normocytic, Normochromic                               |
| Platelets                                                     | **Occasional enlarged, giant**                                                                                   | **Megakaryocytic fragments**                                         | **Megakaryocytic fragments**, **giant**                                | **Marked variation in size and shape**                 |
| <mark class="red">MOLECULAR TESTS</mark>                      | <                                                                                                                | <                                                                    | <                                                                      | <                                                      |
| Philadelphia chromosome                                       | Present                                                                                                          | Absent                                                               | Absent                                                                 | Absent                                                 |
| JAK 2                                                         | Absent                                                                                                           | 95 - 100% cases                                                      | 95 - 100% cases                                                        | ~55%                                                   |
| Marrow fibrosis                                               | Progressively ↑                                                                                                  | Progressively ↑                                                      | Markedly elevated                                                      | Progressively ↑                                        |

^5pc695

> [!NOTE] CML cytogenetic anomaly
> - t(q9;q22)
> - 9 (ABL gene)
> - 22 (BCR gene)

> [!NOTE] Philadelphia chromosome
> -  changed chromosome 22 (fusion of BCR & ABL gene)
> - ![[Pasted image 20240509131620.png]]

> [!NOTE] CML stages
> - Dormant (<10% blasts)
> - Accelerated (10 - 19%)
> - Blast crises (>20%)

# LABORATORY PROCEDURES

|                                                                                           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| ----------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| Improved Neubauer Ruling on the Hemocytometer<br><br>![[Pasted image 20240430153806.png]] | - <mark class="red">WBCs</mark> are usually counted in A, B, C and D. <br>(1:20 = 4 corner squares; 1:100 = all 9 squares)<br>(Volume = 1mm x 1mm x 0.1 mm = 0.1mm 3/uL)<br><br>- <mark class="red">RBCs</mark> are usually counted in the **blue**-colored small squares.<br>(1:100 or 1:200 dilution)<br>(Volume = 0.2 mm x 0.2 mm x 0.1 mm = 0.004 mm3/uL)<br><br>- <mark class="red">Platelets</mark> are usually counted in the **blue**- and **green**-colored small squares.<br>(1:100 dilution)<br>(Volume = 1mm x 1mm x 0.1mm = 0.1 mm3/uL)<br>(Phase Contrast microscope)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| General Formula for Cell Count Using the Neubauer Ruling                                  | ![[Pasted image 20240430154119.png]]<br><br>total vol in chamber counted = (# square counted) x (volume of 1 square)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| <mark class="red">Corrected Wbc Count</mark><br><br>if at least 5 nRBCs are seen          | 100-cell differential<br>![[Pasted image 20240430154146.png]]<br><br>50-cell differential<br>![[Pasted image 20240430154205.png]]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| <mark class="red">Electronic Impedance Counters</mark>                                    | Particles (most often cells) are forced to flow through small openings i.e., apertures, between two electrodes in an ionic solution. As each cell passes thru the aperture, the **electrical resistance** between the two electrodes increases, recorded as **voltage pulses**, because **cells are poor conductors of electricity.**<br><br><mark class="red"># pulse = # of cells</mark><br><mark class="red">amplitude = cell size</mark><br><br>**<mark class="red">WBC count</mark> (in WBC aperture)**. Particles larger than 35fL are counted as WBC.<br>- <mark class="red">**small mononuclear** or **lymphocytes**</mark> = **35 – 90 fL**<br>- <mark class="red">**large mononuclear** or **monocytes**</mark> = **90 – 160 fL**<br>- <mark class="red">**neutrophils** and **other granulocytes**</mark> = **160 – 450 fL**<br><br>**<mark class="red">RBC count</mark> (in RBC aperture)**. Particles in the size range of **36 – 360 fL** are counted as RBCs.<br><br>**<mark class="red">Platelet count</mark> (in RBC aperture)**. Particles in the size range of **2 – 20 fL** are counted as platelets |
| SCHEMA OF IMPEDANCE INSTRUMENT                                                            | ![[Pasted image 20240430154542.png]]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |


> [!NOTE] Basic principles/methods used in automated cell counting
> Electrical Impedance
> Optical (Light) Scatter

> [!NOTE]
> Forward scatter (cell size)
> Side scatter (90°), Orthogonal (cellular granularity/complexity)

## RED BLOOD CELL INDICES

|                                                           |                                                                                                                                                                           |
| --------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">MCV</mark><br><br>NV: **80 - 100 fL**   | Indicates **average size** of RBCs.                                                                                                                                       |
| <mark class="red">MCH</mark><br><br>NV: **26 - 32 pg**    | Indicates **average weight of hemoglobin** per RBC.<br><br>NOT USED for the morphological classification of anemia                                                        |
| <mark class="red">MCHC</mark><br><br>NV: **32 - 36 g/dL** | Represents **average concentration of hemoglobin per 100mL** of packed RBCs (pRBCs).<br><br>if 36 - 38 g/dL (check SPHEROCYTES)<br>if >38 g/dL (check ERRORS in Hgb det.) |


## HISTOGRAMS

A histogram utilizes **impedance technology**. It is a representation of **cell number versus one measured property**, usually cell size.

|                                      |                                             |                                                                                                                                                                                                                                                                    |
| ------------------------------------ | ------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |
| ![[Pasted image 20240430155516.png]] | <mark class="red">WBC </mark> Histogram     | - **35 to 450 fL** is the reference size range for WBCs<br>  - 1st peak (<mark class="red">Lymphocytes</mark>; 35 - 90 fL)<br>  - 2nd peak (<mark class="red">Monocytes</mark>; 90 - 160 fL)<br>  - 3rd peak (<mark class="red">Granulocytes</mark>; 160 - 450 fL) |
| ![[Pasted image 20240430155523.png]] | <mark class="red">RBC</mark> Histogram      | - **36 fL and above** is the reference size range for RBCskk<br>  - A normal RBC histogram will show a **SINGLE peak between 70 to 110 fL** that will correlate with MCV                                                                                           |
| ![[Pasted image 20240430155532.png]] | <mark class="red">Platelet</mark> Histogram | - **2 to 20 fL** is the reference size range for platelets<br><br>occur BEFORE the start of RBC histogram                                                                                                                                                          |

### ABNORMAL WBC HISTOGRAMS

| Finding                                          | Indication                                 |
| ------------------------------------------------ | ------------------------------------------ |
| Population <mark class="red">before 35fL</mark>  | nRBCs; giant or clumped PLT                |
| Peak overlap <mark class="red">at 90fL</mark>    | reactive lymphocytes/ blast cells          |
| Peak overlap <mark class="red">at 160fL</mark>   | ↑ bands (other immature granulocyte forms) |
| Population <mark class="red">after 450 fL</mark> | HIGH granulocyte count                     |

### ABNORMAL RBC HISTOGRAMS

| Finding                                                                                                         | Indication                                                                             |
| --------------------------------------------------------------------------------------------------------------- | -------------------------------------------------------------------------------------- |
| <mark class="red">Two peaks</mark>                                                                              | dimorphic RBC population (1. **2 deficiencies**; 2. **post-transfusion/post-therapy**) |
| <mark class="red">Increase curve width</mark>                                                                   | ↑ RDW; Anisocytosis (variation in cell size)                                           |
| <mark class="red">Shift to the RIGHT</mark><br><br>in relation to the peak ![[Pasted image 20240509143110.png]] | ↑ MCV = MACROcytes                                                                     |
| <mark class="red">Shift to the LEFT</mark>                                                                      | ↓ MCV = MICROcytes                                                                     |

### Conditions That Cause Interferences On MOST HEMATOLOGY ANALYZERS

| CAUSE                                                                                                                                             | EFFECT                                                                                     | REMEDY                                                        |
| ------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------ | ------------------------------------------------------------- |
| <mark class="red">Cold agglutinins</mark><br><br>anti-i, anti-I                                                                                   | ↓ RBCs, ↑MCV<br><br>Indicator: Shift to RIGHT in RBC histogram                             | Warm the spx & rerun the sample                               |
| <mark class="red">Lipemia, icterus, chylomicrons</mark>                                                                                           | ↑ Hb, ↑MCHC, ↑MCH<br><br>Indicator: Hgb x3 ≠ Hct                                           | Replace the plasma                                            |
| <mark class="red">Lysis-resistant RBCs</mark> with **abnormal hemoglobin**                                                                        | Hb S, Hb C, HbF<br>↑ WBC ct. ↑Hgb<br><br>Indicator: interference on histogram              | Manual dilution (adjust tonicity)                             |
| <mark class="red">Platelet clumps</mark><br><br>Platelet satellitosis                                                                             | ↓ PLT ct, ↑ WBCs<br><br>Indicator: interference on histogram                               | Collect a new spx using CITRATE and multiply result by 1.1    |
| <mark class="red">Hemolysis</mark>                                                                                                                | ↓RBC ct; ↑Hct<br><br>Hematocrit (derived from RBC ct & MCV)<br><br>Indicator: Hgb x3 ≠ Hct | Similar histogram picture w/ LIPEMIA<br><br>Request a NEW spx |
| <mark class="red">Microcytes</mark> or <mark class="red">Schistocytes</mark>                                                                      | ↓RBC ct; ↑PLT ct<br><br>Indicator: LEFT shift on RBC histogram & ABnormal PLT histogram    | Review the blood film                                         |
| <mark class="red">Nucleated RBCs</mark>, <mark class="red">Megakaryocyte fragments</mark><br><br>(tend to be present in OLD hematology analyzers) | ↑WBC ct                                                                                    | Corrected by NEWER instruments                                |

^ix663k

## RETICULOCYTE COUNT

> [!NOTE]
> INDICATOR of BM response 

- provides a measure of erythropoiesis and often used to assess the **bone marrow's response** to anemia.
- Manual methods use **supravital stains** such as <mark class="red">new methylene blue</mark> or <mark class="red">brilliant cresyl blue</mark>.

|                                                          |                                                                                                                                                                                                      |
| -------------------------------------------------------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| ![[Pasted image 20240430155745.png]]                     | Appearance of reticulocytes under <mark class="red">Wright stain</mark>.<br>Polychromatic macrocytes                                                                                                 |
| ![[Pasted image 20240430155755.png]]                     | Appearance of reticulocytes after <mark class="red">supravital staining</mark> (black arrows). Heinz bodies may also be stained (red arrows)                                                         |
| <mark class="red">RELATIVE</mark> Reticulocyte Count<br> | uses a MILLER DISC<br>NV: 0.5 - 1.5%                                                                                                                                                                 |
| <mark class="red">ABSOLUTE</mark> Reticulocyte Count<br> | actual # of retics per L of whole blood<br>NV: 25 - 75 x 109/L                                                                                                                                       |
| <mark class="red">CORRECTED</mark> Reticulocyte Count    | spx have ↑HCT = falsely HIGH retic ct<br>NV: 35% = 2 - 3%; <25% = 3 - 5%                                                                                                                             |
| <mark class="red">Reticulocyte Production Index</mark>   | Maturation Time<br>36-45 = 1.0<br>26-35 = 1.5<br>16-25 = 2.0<br>≤ 15 = 3.0<br><br>SHIFT reticulocytes (prematurely released into the circulation)<br><br>>3% (adequate response)<br><2% (INadequate) |



## ERYTHROCYTE SEDIMENTATION RATE

- **NONspecific** measurement used to detect and monitor an **inflammatory response**
- **settling of RBCs** at the bottom of a tube upon standing **undisturbed for 1 hour**
- distance in **milliliters** that the RBCs fall in 1 hour

## FACTORS AFFECTING ESR RESULT

> [!NOTE]
> very important in ESR (<mark class="red">ROULEAUX Formation</mark>)
> NO Rouleaux = ↓ ESR

|                                                                               | DECREASE                                                                                               | INCREASE                                                                                                                                                                     |
| ----------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------ | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">RBC</mark> FACTORS                                          | **Microcytes**<br>**Anisocytes**<br>**Poikilocytes**<br>**Polycythemia** (due to taller column)        | **Macrocytes**<br>**Anemia** (due to ↓Hct)                                                                                                                                   |
| <mark class="red">PLASMA</mark> FACTORS<br><br>single & most important factor | **Albumin** (zeta potential prevents rouleaux formation)                                               | **Fibinogen**<br>**Globulins**                                                                                                                                               |
| <mark class="red">TECHNICAL</mark> FACTORS #table-column                      | **Delay in <mark class="red">TESTING</mark>** (crenated)<br>**Overanticoagulation** (crenated)<br><br> | **Tilting** of tube<br>**Increased temperature**<br>**Mechanical vibration**<br>**Length and diameter of tube**<br><br>**Delay in <mark class="red">READING</mark>** (↑ ESR) |

^gapozd


## LAP STAINING TECHNIQUE

> [!NOTE]
> differentiates CML vs LR

- stains the <mark class="red">alkaline phosphatase</mark> present in **neutrophils** (mature forms only) and to a small degree, in certain **B lymphocytes**
- this is helpful in the differentiation of <mark class="red">chronic myelogenous</mark> from <mark class="red">leukemoid reaction</mark> and <mark class="red">polycythemia vera</mark>.
- the specimen of choice is <mark class="red">fresh capillary blood</mark>, but alternatively blood may be collected using <mark class="red">heparin</mark> as anticoagulant.
- & <mark class="red">Kaplow count</mark> is performed where a total of **100 neutrophils** are scored from 0 (negative) to 4 (strongly positive) based upon the intensity of staining reaction.

EXAMPLE


| Staining Grade    | 1+  | 2+  | 3+  | 4+  |
| ----------------- | --- | --- | --- | --- |
| # of Cell Counted | 50  | 30  | 10  | 10  |
| LAP Score         | 180 | <   | <   | <   |

## CONDITIONS ASSOCIATED WITH LAP SCORING

|                                    |                                                                                                                                                                                                                                                                                             |
| ---------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| <mark class="red">INCREASED</mark> | - **<mark class="red">Leukemoid reaction</mark>**<br>- **<mark class="red">Polycythemia vera</mark>**<br>- **3rd Trimester** of pregnancy<br>- **Infection (Neutrophilia)**<br>- **Multiple myeloma**<br>- **Corticosteroid therapy**<br>- **Myelosclerosis**<br>- **Obstructive jaundice** |
| <mark class="red">DECREASED</mark> | - **<mark class="red">Chronic myelogenous leukemia</mark>**<br>- **Paroxysmal nocturnal hemoglobinuria**<br>- **Sickle cell anemia**<br>- **Sideroblastic anemia**<br>- **Hereditary hypophosphatasemia**<br>- **Marked eosinophilia**<br>- **Rarely** in normal people                     |
| <mark class="red">NORMAL</mark>    | - **Untreated hemolytic anemia**<br>- **Lymphosarcoma**<br>- **Viral hepatitis**<br>- **Secondary polycythemia**                                                                                                                                                                            |

^v8y6pk

## Immunophenotyping
- Valuable tool in **diagnosing** hematology malignancy
- Used **MONOclonal antibodies** to help subclassify leukemia and define other abnormalities
- **Acute MYELOID Leukemia** (refer to AML table)
- ~ **Acute LYMPHOBLASTIC Leukemia**
1. B cell (immunologic subgroups define by immunophenotype)
	- Early precursor (**pro-B** cell) B cell ALL: CD<mark class="red">34</mark> (most significant), CD<mark class="red">19</mark>, <mark class="red">TdT</mark>, <mark class="red">HLA-DR</mark>
	- **Intermediate pre-B** cell ALL: CD<mark class="red">10</mark> (most significant), CD<mark class="red">19</mark>, <mark class="red">HLA-DR</mark>, TdT, CD<mark class="red">34</mark> (sometimes)
	- Pre-B cell ALL: CD<mark class="red">19</mark>, <mark class="red">cIg</mark>, <mark class="red">HLA-DR</mark>, <mark class="red">TdT</mark>, CD<mark class="red">22</mark>, CD<mark class="red">10</mark> (sometimes)
2. T cell: CD<mark class="red">2</mark>, CD<mark class="red">3</mark>, CD<mark class="red">4</mark>, CD<mark class="red">5</mark>, CD<mark class="red">7</mark>, CD<mark class="red">8</mark>, <mark class="red">TdT</mark>
3. Selected lymphomas

### IMMUNOPHENOTYPE OF SELECTED MATURE B-CELL NEOPLASMS

| #table-column                                                | <mark class="red">CLL (Chronic Lymphocytic Leukemia)</mark> | <mark class="red">MCL (Mantle Cell Lymphoma)</mark> | <mark class="red">FL (Follicular Lymphoma)</mark> | <mark class="red">MZL (Marginal Zone Lymphoma) or <br>SVL (Splenic Lymphoma w/ Villous Lymphocytes)</mark> |
| ------------------------------------------------------------ | ----------------------------------------------------------- | --------------------------------------------------- | ------------------------------------------------- | ---------------------------------------------------------------------------------------------------------- |
| CD<mark class="red">19</mark>                                | <mark class="red">+++</mark>                                | <mark class="red">+++</mark>                        | <mark class="red">++/±</mark>                     | <mark class="red">+++</mark>                                                                               |
| CD<mark class="red">20</mark>                                | <mark class="red">+</mark>                                  | <mark class="red">+++</mark>                        | <mark class="red">+++</mark>                      | <mark class="red">+++</mark>                                                                               |
| CD<mark class="red">79a</mark>                               | <mark class="red">+/-</mark>                                | <mark class="red">+</mark>                          | <mark class="red">+</mark>                        | <mark class="red">+</mark>                                                                                 |
| CD<mark class="red">5</mark>                                 | <mark class="red">+</mark>                                  | <mark class="red">+</mark>                          | <mark class="red">-</mark>                        | <mark class="red">-</mark>                                                                                 |
| CD<mark class="red">23</mark>                                | <mark class="red">+</mark>                                  | <mark class="red">-</mark>                          | <mark class="red">+</mark>                        | <mark class="red">-</mark>                                                                                 |
| <mark class="red">FMC7</mark>                                | <mark class="red">-</mark>                                  | <mark class="red">+</mark>                          | <mark class="red">+</mark>                        | <mark class="red">+</mark>                                                                                 |
| CD<mark class="red">11c</mark>                               | <mark class="red">+</mark>                                  | <mark class="red">-</mark>                          | <mark class="red">-</mark>                        | <mark class="red">+</mark>                                                                                 |
| CD<mark class="red">25</mark>                                | <mark class="red">-</mark>                                  | <mark class="red">-</mark>                          | <mark class="red">-</mark>                        | <mark class="red">-/+</mark>                                                                               |
| CD<mark class="red">10</mark>                                | <mark class="red">-</mark>                                  | <mark class="red">-</mark>                          | <mark class="red">+</mark>                        | <mark class="red">-</mark>                                                                                 |
| <mark class="red">slg</mark> #table-center-1 #table-small-sr | <mark class="red">+/-</mark> #text-center                   | <mark class="red">++</mark>                         | <mark class="red">+++</mark>                      | <mark class="red">+++</mark>                                                                               |

^f88016


|                                                                                                        | CD<mark class="red">19</mark> | CD<mark class="red">20</mark> | CD<mark class="red">79a</mark> | CD<mark class="red">5</mark> | CD<mark class="red">23</mark> | <mark class="red">FMC7</mark> | CD<mark class="red">11c</mark> | CD<mark class="red">25</mark> | CD<mark class="red">10</mark> | <mark class="red">slg</mark> |
| ------------------------------------------------------------------------------------------------------ | ----------------------------- | ----------------------------- | ------------------------------ | ---------------------------- | ----------------------------- | ----------------------------- | ------------------------------ | ----------------------------- | ----------------------------- | ---------------------------- |
| <mark class="red">CLL (Chronic Lymphocytic Leukemia)</mark>                                            | <mark class="red">+++</mark>  | <mark class="red">+</mark>    | <mark class="red">+/-</mark>   | <mark class="red">+</mark>   | <mark class="red">+</mark>    | <mark class="red">-</mark>    | <mark class="red">+</mark>     | <mark class="red">-</mark>    | <mark class="red">-</mark>    | <mark class="red">+/-</mark> |
| <mark class="red">MCL (Mantle Cell Lymphoma)</mark>                                                    | <mark class="red">+++</mark>  | <mark class="red">+++</mark>  | <mark class="red">+</mark>     | <mark class="red">+</mark>   | <mark class="red">-</mark>    | <mark class="red">+</mark>    | <mark class="red">-</mark>     | <mark class="red">-</mark>    | <mark class="red">-</mark>    | <mark class="red">++</mark>  |
| <mark class="red">FL (Follicular Lymphoma)</mark>                                                      | <mark class="red">++/±</mark> | <mark class="red">+++</mark>  | <mark class="red">+</mark>     | <mark class="red">-</mark>   | <mark class="red">+</mark>    | <mark class="red">+</mark>    | <mark class="red">-</mark>     | <mark class="red">-</mark>    | <mark class="red">+</mark>    | <mark class="red">+++</mark> |
| <mark class="red">MZL (Marginal Zone Lymphoma) or SVL (Splenic Lymphoma w/ Villous Lymphocytes)</mark> | <mark class="red">+++</mark>  | <mark class="red">+++</mark>  | <mark class="red">+</mark>     | <mark class="red">-</mark>   | <mark class="red">-</mark>    | <mark class="red">+</mark>    | <mark class="red">+</mark>     | <mark class="red">-/+</mark>  | <mark class="red">-</mark>    | <mark class="red">+++</mark> |

^e8rp1y
